CDC42 activity-specific inhibitor (Novo Nordisk)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCDC42 activity-specific inhibitor (Novo Nordisk)
Drug Alias NameCASIN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division control protein 42 homolog inhibitors
TargetsCell division control protein 42 homolog
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNovo Nordisk (China)Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk (China)Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A